A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization

The role of anti-VEGF agents in myopic choroidal neovascularization: Current standards and future outlook

(2016) Marion R. Munk et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Targeting VEGF in eye neovascularization: What's new?

(2016) Marialaura Amadio et al.   PHARMACOLOGICAL RESEARCH

Experimental autoimmune uveitis and other animal models of uveitis: An update

(2015) Rupesh Agrawal et al.   INDIAN JOURNAL OF OPHTHALMOLOGY

Parainflammation, chronic inflammation, and age-related macular degeneration

(2015) M. Chen et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Uveitis

(2015) James P. Dunn   PRIMARY CARE

Immune mechanisms in inflammatory and degenerative eye disease

(2015) Victor L. Perez et al.   TRENDS IN IMMUNOLOGY

Anti-VEGF therapies in the treatment of choroidal neovascularisation secondary to non-age-related macular degeneration: a systematic review

(2015) A. Stuart et al.   BMJ Open

Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy

(2015) Selwyn M. Prea et al.   Journal of Ophthalmology

Comparing aflibercept, bevacizumab, and ranibizumab for DME: Analysis of DRCR Protocol T

(2015) Charles C. Wykoff et al.   Ophthalmic Surgery Lasers & Imaging Retina

Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factors

(2015) Anne Louise Askou et al.   Molecular Therapy-Methods & Clinical Development

A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I

(2014) Kyungmin Lee et al.   EXPERT OPINION ON PHARMACOTHERAPY

Oral Delivery of ACE2/Ang-(1–7) Bioencapsulated in Plant Cells Protects against Experimental Uveitis and Autoimmune Uveoretinitis

(2014) Pollob K Shil et al.   MOLECULAR THERAPY

Side-Effects of Anti-Inflammatory Therapy in Uveitis

(2014) Eduardo Uchiyama et al.   Seminars in Ophthalmology

Long-term follow-up of vascular endothelial growth factor inhibitor therapy for neovascular age-related macular degeneration

(2013) Adrienne W. Scott et al.   CURRENT OPINION IN OPHTHALMOLOGY

Emerging drugs for the treatment of uveitis

(2013) Theresa G Leung et al.   EXPERT OPINION ON EMERGING DRUGS

Ocular neovascularization

(2013) Peter A. Campochiaro   JOURNAL OF MOLECULAR MEDICINE-JMM

Inflammation and oxidative stress in angiogenesis and vascular disease

(2013) Young-Woong Kim et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy

(2013) Chang-Sue Yang et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Mechanisms of age-related macular degeneration and therapeutic opportunities

(2013) Menno van Lookeren Campagne et al.   JOURNAL OF PATHOLOGY

A Comprehensive Review of Retinal Gene Therapy

(2013) Shannon E Boye et al.   MOLECULAR THERAPY

Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice

(2013) Vincent Lambert et al.   Nature Protocols

Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration

(2013) Zohar Yehoshua et al.   OPHTHALMOLOGY

Use of Optical Coherence Tomography and Electroretinography to Evaluate Retinal Pathology in a Mouse Model of Autoimmune Uveitis

(2013) Jun Chen et al.   PLoS One

VEGF Receptor Blockade Markedly Reduces Retinal Microglia/Macrophage Infiltration into Laser-Induced CNV

(2013) Hu Huang et al.   PLoS One

Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug

(2012) Michael W Stewart   BRITISH JOURNAL OF OPHTHALMOLOGY

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

(2012) Jeffrey S. Heier et al.   OPHTHALMOLOGY

Clinical applications of retinal gene therapy

(2012) Daniel M. Lipinski et al.   PROGRESS IN RETINAL AND EYE RESEARCH

Vascular endothelial growth factors in retinal and choroidal neovascular diseases

(2011) Kati Kinnunen et al.   ANNALS OF MEDICINE

Relationship between Complement Membrane Attack Complex, Chemokine (C-C Motif) Ligand 2 (CCL2) and Vascular Endothelial Growth Factor in Mouse Model of Laser-induced Choroidal Neovascularization

(2011) Juan Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Vascular endothelial growth factor inhibition in uveitis: a systematic review

(2010) N. Gulati et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis

(2010) Mei Chen et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment

(2010) Y Wang et al.   EYE

Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina

(2010) Hilda Petrs-Silva et al.   MOLECULAR THERAPY

Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab

(2009) K Weiss et al.   EYE

Characterizing Extravascular Neutrophil Migration In Vivo in the Iris

(2008) Stephen R. Planck et al.   INFLAMMATION

Downregulation of p22phox in Retinal Pigment Epithelial Cells Inhibits Choroidal Neovascularization in Mice

(2008) Qiuhong Li et al.   MOLECULAR THERAPY

High-efficiency Transduction of the Mouse Retina by Tyrosine-mutant AAV Serotype Vectors

(2008) Hilda Petrs-Silva et al.   MOLECULAR THERAPY

Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis

(2007) Kousuke Noda et al.   FASEB JOURNAL